← Back to guidelines
Cardiology11272 papers

Acute coronary syndrome

Last edited: 4/23/2026

Overview

Acute coronary syndrome (ACS) encompasses a spectrum of clinical presentations including unstable angina and myocardial infarction, characterized by reduced blood flow to the heart muscle due to coronary artery disease. Early diagnosis and management are crucial to mitigate morbidity and mortality 1.

Diagnosis

  • Clinical Presentation: Chest pain, shortness of breath, nausea, sweating 1.
  • Electrocardiogram (ECG): ST-segment elevation (STEMI) or depression (NSTEMI), T-wave inversions 112.
  • Cardiac Biomarkers: Elevated high-sensitivity troponin levels 112.
  • Coronary Angiography: Visual confirmation of coronary artery occlusion 7.
  • Risk Stratification Tools: HEART score, GRACE score for prognostic assessment 737.
  • Management

  • Antiplatelet Therapy: Early initiation of dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor (e.g., ticagrelor, prasugrel) 31948.
  • Anticoagulation: Use of anticoagulants like heparin or bivalirudin, especially in PCI 119.
  • Primary PCI: Prompt revascularization for STEMI patients 714.
  • Beta-Blockers: Initiation post-MI to reduce mortality 1.
  • ACE Inhibitors/ARBs: Used to reduce afterload and improve outcomes 1.
  • Lipid Management: Statins for LDL-C reduction 133.
  • Special Populations

  • Elderly: Consider frailty and comorbidities when tailoring treatment; close monitoring advised 59.
  • Women: Equal benefit from cardiac rehabilitation noted; tailored risk stratification recommended 436.
  • Comorbidities: Obstructive sleep apnea increases recurrent event risk in younger patients but not older ones 15.
  • Key Recommendations

  • Initiate Dual Antiplatelet Therapy (DAPT) Early: Aspirin plus a P2Y12 inhibitor for ACS patients (Evidence: Strong 319).
  • Prompt Primary PCI for STEMI: Within 90-120 minutes of first medical contact (Evidence: Strong 714).
  • Use of High-Sensitivity Troponin for Diagnosis: For accurate and timely identification of myocardial injury (Evidence: Moderate 112).
  • Cardiac Rehabilitation: Recommended for all ACS patients to improve outcomes, with equal benefit noted across sexes (Evidence: Moderate 4).
  • Consider Patient Frailty in Older Adults: Tailor management strategies to account for frailty status (Evidence: Moderate 59).
  • References

    Showing 100 most recent of 4442 indexed papers.

    1 Farfan Medina LE. Comparative Analysis of 2025 American College of Cardiology/American Heart Association/Multisociety and 2023 European Society of Cardiology Acute Coronary Syndrome Guidelines: Implications for Advanced Practice Registered Nurses. Journal of the American Association of Nurse Practitioners 2026. link 2 Viana-Tejedor A, Martínez Losas P, Andrea-Riba R, Corbí-Pascual M, Rosillo S, Alonso JJ et al.. Intermediate cardiac care units: rationale, resources, and admission criteria. Position statement of the SEC-ACICAC. Revista espanola de cardiologia (English ed.) 2026. link 3 Angiolillo DJ, Erlinge D, Gale CP, Gorog DA, Ibañez B, Musumeci G et al.. Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey. International journal of cardiology 2026. link 4 Ter Hoeve N, De Bakker M, Sunamura M, Roeters van Lennep JE, Boersma E, Van den Berg-Emons RJG. Women and men profit equally from cardiac rehabilitation: a secondary analysis of the OPTICARE RCT. Journal of rehabilitation medicine 2026. link 5 Manandi D, Brieger D, Redfern J, Tu Q, Briffa T, Hafiz N et al.. Socioeconomic Variation in the Association Between Participation in Cardiac Rehabilitation and Clinical Outcomes in Patients With Acute Coronary Syndrome. Journal of cardiopulmonary rehabilitation and prevention 2026. link 6 Zeng Y, Lu L, Jiang T, Wei G, Zheng W, Chen G. Respiratory, thoracic, and mediastinal adverse events associated with ticagrelor: A pharmacovigilance study based on FDA adverse event reporting system. Naunyn-Schmiedeberg's archives of pharmacology 2026. link 7 Ozaki Y, Tobe A, Onuma Y, Miyashita K, Kobayashi Y, Amano T et al.. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026. Cardiovascular intervention and therapeutics 2026. link 8 Homami S, Zinvand-Moghaddam F, Rassouli M, Valinejadi A, Ebrahimian A. Assessment of Compliance with Nursing Care Documentation for Patients with Acute Coronary Syndrome Using the Clinical Care Classification System in the Emergency Department: A Descriptive and Directed Content Analysis Study. Critical care nursing quarterly 2026. link 9 Guo Y, Li J, Zhang L. miR-203 Alleviates Myocardial Damage Caused by Acute Coronary Syndrome by Inhibiting CA125. Biochemical genetics 2026. link 10 Hyun HK, Lee OH, Roh JW, Heo SJ, Huh CW, Kim Y. Evaluation of Rabeprazole for Gastrointestinal Protection in Acute Coronary Syndrome Patients Treated with Aspirin and Ticagrelor: A Pilot Study. Yonsei medical journal 2026. link 11 Wang M, Wu X, Ke Y, Zhu C, Xie J, Jin J. Influencing factors of patient delay for decision-making in older patients with acute coronary syndrome: a study based on the Andersen's Behavioral Model. Frontiers in public health 2026. link 12 Feng ZQ, Xu F, Fu YN, Yang FF, Li Y, Yang BH et al.. Performance of the ESC 0/1 h hs-cTnI algorithm in suspected NSTEMI patients with normal versus abnormal electrocardiograms. The American journal of emergency medicine 2026. link 13 Laughter C, Alsayyed A, Shubair M, Johnson A, Awad E. Comparing physician and advanced care provider use of opioids for treatment of acute chest pain in the emergency department. The American journal of emergency medicine 2026. link 14 Gnanaraj JP, Saaminathan K, Steaphen AP, Sethupathy S, Mohammed I, Kurien S et al.. Extended Pharmacoinvasive PCI Compared to Primary PCI: Insights From Madras Medical College STEMI Registry. The American journal of cardiology 2026. link 15 Gong W, Chen X, Zhao W, Du J, Zhang Z, Fan J et al.. Obstructive sleep apnea increases recurrent cardiovascular event risk in younger but not older patients with acute coronary syndrome: a prospective cohort study. Sleep medicine 2026. link 16 De Y, Han Y, Song Y, Zhang X, Wu S, Wang B et al.. Joint effects of pulse pressure and LVEF on 12-month mortality in acute coronary syndrome patients undergoing PCI. International journal of cardiology 2026. link 17 Fernández-Pombo CN, Aldama-López G, Lorenzo-Carpente M, López-Perez M, Marzoa-Rivas R, Rodríguez-Fernández JÁ et al.. A Remote Nursing-Guided Secondary Prevention Programme in Acute Coronary Syndrome. The SPRING Randomised Controlled Trial. Journal of advanced nursing 2026. link 18 Safarabadi M, Farsani SM, Mohammadtalebi H, Kamani R, Mousivand M. Effects of the Buteyko breathing technique on sleep quality, fatigue, and oxygen saturation in patients with acute coronary syndrome: a randomized controlled trial. BMC cardiovascular disorders 2026. link 19 Kulsumritpon N. Short-Course Potent P2Y. Cardiovascular drugs and therapy 2026. link 20 De Vita A, Marino AG, Cambise N, Lamendola P, Tremamunno S, Mollo F et al.. Coronary microvascular dysfunction in patients with acute coronary syndrome and non-obstructive coronary artery disease: a 10-year clinical follow-up study. International journal of cardiology 2026. link 21 Wang Y, Chen Z, Shen J, Song J, Lan M. Comparative accuracy of risk prediction models for mortality in acute coronary syndrome: A protocol for systematic review and meta analysis. Medicine 2026. link 22 Sørgaard MH, Kristensen AT, Eskesen K, Kofoed KF, Linde JJ, Kelbæk H et al.. Coronary computed tomography angiography versus invasive coronary angiography for interventional triage in acute coronary syndrome: Design of the randomized TRACTION trial. American heart journal 2026. link 23 Herlaș-Pop A, Radu AF, Radu A, Bungau GS, Tit DM, Babes EE et al.. The Mental Health-Acute Coronary Syndrome Continuum: Bidirectional Pathophysiological Links and Clinical Implications. Medical sciences (Basel, Switzerland) 2026. link 24 Dudzikowska M, Rębak D, Gotlib-Małkowska J, Chmielewski J, Sierpiński R, Goździewska M et al.. Effect of overweight and obesity on clinical course and prognosis in patients with acute coronary syndromes. Annals of agricultural and environmental medicine : AAEM 2026. link 25 Elbahloul MA, Gadelmawla AF, Ali AHG, Awad AK, Elazab A, Mansour A et al.. Coronary artery bypass grafting versus percutaneous coronary intervention outcomes among patients with acute coronary syndrome and unprotected left main coronary artery disease: a meta-analysis with a reconstructed time-to-event analysis. Expert review of cardiovascular therapy 2026. link 26 Wang H, Sun X, Wu F, Liu Z, Li Z, Tong Q et al.. Redox-mediated synthesis of Kiwi-like hybrid nanoparticles enabling multimode lateral flow immunoassay for detection of cardiac troponin I. Biosensors & bioelectronics 2026. link 27 Rylance R, Wagner P, Götberg M, Mohammad MA, Hofmann R, Fröbert O et al.. Win statistics applied to registry-based randomized clinical trials. Trials 2026. link 28 Gülle S, Ekmekci C, Akar H, Özdoğan Ö. The Importance of Arterial Stiffness Parameters for Predicting Syntax Score in Acute Coronary Syndrome. Romanian journal of internal medicine = Revue roumaine de medecine interne 2026. link 29 Kumar S, Giri AR, Nair RM, Kassis N, Kumar A, Huded CP et al.. Impact of Comprehensive STEMI Protocol on Process Metrics and Clinical Outcomes in STEMI Patients With Nonsystem Delays. The American journal of cardiology 2026. link 30 Pereira AMB, Rosa AA, Flávio-Reis VHP, Pessoa-Gonçalves YM, Desidério CS, Coelho MFG et al.. Outcomes and Risk Profiles of Acute Coronary Syndrome Patients Treated With Percutaneous Coronary Intervention: Insights From a Brazilian Tertiary Care Center. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 31 Shu Y, Wang L, Wang Y, Tan J, Zhang H, Yang Y. Association Between Anemia and Prognosis in Patients With Acute Coronary Syndrome and Atrial Fibrillation. Angiology 2026. link 32 Saczek J, Dann A, Crapnell RD, Banks CE, Johnson RE, Canfarotta F et al.. Unlocking interstitial fluid for acute coronary syndrome diagnosis: ultrasensitive troponin I detection using imprinted polymer nanoparticles. Nanoscale horizons 2026. link 33 Chen X, Li S, Wang B, Chen G, Yao Y, He Y et al.. Staged interventional strategies for acute ST-segment elevation myocardial infarction patient with multivessel disease: Rationale and design of a multicenter, randomized STAGED trial. American heart journal 2026. link 34 Zhang J, Jia X, Zhu P, Zhao M, Du H, Yu X et al.. Homocysteine activates endothelial TP receptor to promote von Willebrand factor secretion and thrombosis. Journal of molecular and cellular cardiology 2026. link 35 Ji RQ, Riek NT, Bouzid Z, Kraevsky-Phillips K, Gokhale T, Zegre-Hemsey JK et al.. Adversarial Debiasing for Equitable and Fair Detection of Acute Coronary Syndrome Using 12-Lead ECG. IEEE transactions on bio-medical engineering 2026. link 36 Kovacic JC, Reynolds HR, Alasnag M, Blakeman JR, Ijioma NN, Kim ESH et al.. Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association. Circulation 2026. link 37 Cirillo P, Di Serafino L, Scalamogna M, De Rosa G, Calabrò P, Antonucci E et al.. ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET Registry. Angiology 2026. link 38 Khaled S, Tantawi W, Ahmed WE, Shaikh M, Alkhatib A, Bahattab A et al.. The impact of post discharge virtual cardiac remote monitoring for patients with acute coronary syndrome during HAJJ season 1445H- KAMC experience. International journal of cardiology 2026. link 39 Koolikad AR, Khan SA, Shahzaib M, Arif B, Singla S, Singla B et al.. Diagnostic accuracy of 18-lead versus 12-lead electrocardiography in acute coronary syndrome: A systematic review and meta-analysis. Journal of electrocardiology 2026. link 40 Ocak M, Çömez VV, Yadigaroğlu M, Görgün S, Köprülü D, Güzel M et al.. The Role of VEGF-A in Young Patients with Acute Coronary Syndrome. Clinical laboratory 2026. link 41 Lin X, Wang Y, Tan S, Kuang C, Huang Y, Zhao J et al.. Long-term safety, effectiveness, and cost of rapamycin- vs. everolimus-eluting stents in acute coronary syndrome: a real-world cohort study. International journal of clinical pharmacy 2026. link 42 Tavares CAM, Guimarães PO, Franken M, Junior JM, Lemos S, Almeida BO et al.. Potent P2Y. Journal of the American College of Cardiology 2026. link 43 Tudino R, Richardson E, Gonzalez JM, Barghout M, Ho T, Abbott JD et al.. Acute coronary-occlusion myocardial infarctions: performance of the STEMI criteria and evolving alternative approaches. Trends in cardiovascular medicine 2026. link 44 Lim Y, Park S, Joo D, Lee YK, Oh S, Lee SH et al.. Immediate versus delayed coronary angiography in patients with non-ST segment elevation acute coronary syndrome complicated with acute decompensated heart failure: The EARLY-HF randomized clinical trial. Cardiovascular revascularization medicine : including molecular interventions 2026. link 45 Imboden MT, Koltner E, Bryant JH, Jones A, Swanson RC, Tam LM et al.. Sex Disparities in Acute Myocardial Infarction Diagnosis and Treatment. The American journal of cardiology 2026. link 46 Keremu M, Zhou ZX, Li XL, Li XM, Liu F, Wulamu A et al.. Small Dense Low-density Lipoprotein Cholesterol as a Prognostic Risk Factor in Premature Acute Coronary Syndrome with Multivessel Disease: A Retrospective Cohort Study. Journal of atherosclerosis and thrombosis 2026. link 47 Ma WR, Li Q, Wang Q, Cheng YW, Nai CS, Wang XY et al.. Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST elevation acute Coronary syndrome: a randomized optical coherence Tomography imaging study (EXPECT). The international journal of cardiovascular imaging 2026. link 48 Khan M, Janjua MAH, Akhtar SMM, Al-Qaraghuli A, Al-Shammari AS, Al Sakini AS et al.. Efficacy and Safety of Aspirin-free versus Aspirin-based Strategies in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Journal of cardiovascular pharmacology 2026. link 49 Hongsakul T, Chumsantivut S, Siriyotha S, Athisakul S, Sansanayudh N, Thakkinstian A et al.. In-hospital outcomes of percutaneous coronary intervention (PCI) patients with different medical funds: an analysis from Thai PCI registry. Open heart 2026. link 50 Ahmed M, Wade V, Stacey I, Sodhi-Berry N, Youens D, Haynes E et al.. Temporal Trends in Acute Coronary Syndrome Incidence in Aboriginal and Non-Aboriginal People in Western Australia. Circulation. Population health and outcomes 2026. link 51 Sahoo SK, Barik R, Sathia S, Mohanty CR. Challenges of Coronary Access in Acute Coronary Syndrome With Severe Peripheral Arterial Disease: A Fatal Case. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 52 Verdoia M, Viola O, Rognoni A. Dealing With Calcium in STEMI: A Unique Case of Intracoronary Fracture and Rescue of a Guide Catheter Extension. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 53 Raposeiras-Roubín S, Abu Assi E, Jiménez Méndez C, Mínguez de la Guía E, Pérez Rivera JÁ, Marcos Mangas M et al.. Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial. Circulation 2026. link 54 Roshan PK. Right bundle-branch block (RBBB) and acute coronary syndrome (ACS) a narrative review. The American journal of emergency medicine 2026. link 55 Gwizdala J, Salihu A, Senouf O, Meier D, Rotzinger D, Qanadli S et al.. AI-Driven multi-view learning from CCTA for myocardial infarction diagnosis. The international journal of cardiovascular imaging 2026. link 56 Rao C, Wang W, Che H, Zhong Q, Li Z, Liu W et al.. Development and validation of predictive models for prognostic assessment in patients with acute non-ST-segment elevation myocardial infarction: a multicentre real-world study from China. BMC medical informatics and decision making 2026. link 57 Murray E, Munoz K, Hopkins E, Gravitz S, Haukoos J, Trent S. Associations Between Sex, Race/Ethnicity, and HEART Score Guideline Implementation for Cardiac Testing in the Emergency Department. The Journal of emergency medicine 2026. link 58 Myrmel GMS, Helseth R, Steiro OT, Tjora HL, Langørgen J, Bjørneklett RO et al.. Circulating Markers of Neutrophil Extracellular Traps for Long-Term Prognosis in Patients With Acute Chest Pain. Journal of the American Heart Association 2026. link 59 Fishman B, Segev A, Ashri S, Lerman TT, Sultani S, Beigel R et al.. Frailty Modifies the Prognostic Effect of Age Among Older Adults With Acute Coronary Syndrome. Journal of the American Heart Association 2026. link 60 Barbeito-Caamaño C, Bouzas-Mosquera A, Peteiro-Vázquez J, Fuentes-Vivero A, Vilasanchez-Vilar J, López-Vázquez D et al.. Diagnostic and prognostic value of the risk factor-weighted clinical likelihood model in acute chest pain and negative troponin. The American journal of emergency medicine 2026. link 61 Brookes JDL, Sadiqi S, Chengalath M, Ring H, Morley C, Hogan K et al.. Safety of Early Coronary Surgery in Antiplatelet Non-Responders: A Retrospective Cohort Study. Heart, lung & circulation 2026. link 62 Heaney B, Zalar K, Flores M, Jessee S, Watkins E. Nitroglycerin use in STEMI locations. JAAPA : official journal of the American Academy of Physician Assistants 2026. link 63 Nair S, Bhat D, Hebbar S, Upadhyaya R, Bhat K, Bhat M A. Methylergometrine-induced acute coronary vasospasm in a postpartum patient following caesarean delivery of DCDA twins. BMJ case reports 2026. link 64 Oliva A, Cao D, Shneyderman M, Serrao G, Gitto M, Di Muro FM et al.. Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCI. Journal of thrombosis and thrombolysis 2026. link 65 Pozzessere P, Di Lauro M, Incantalupo F, Cinquantasei A, Palazzo S, Lepera ME et al.. Evaluating the Efficacy of CPS, HEART and TIMI Score in Emergency Department Patients with Non-Traumatic Chest Pain: A Pilot Study. Medical sciences (Basel, Switzerland) 2026. link 66 Ishii Y, Kure M, Kawasumi H, Numaziri Y, Tanizaki Y, Takei Y et al.. Endothelial dysfunction in plaque rupture and plaque erosion. Heart and vessels 2026. link 67 Zhang L, Shi W, Zhao E, Hyun KK, Zecchin R, Gao Y et al.. Effectiveness of a co-adapted virtual discharge education app on disease knowledge and health behaviours in patients following heart attack: a multicentre, randomised controlled trial protocol in Sydney, Australia. BMJ open 2026. link 68 Teng Y, Hoshino M, Kanaji Y, Sugiyama T, Misawa T, Hada M et al.. Predictors and prognostic value of coronary computed tomography angiography for unrecognized myocardial infarction in patients with chronic coronary syndrome. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2026. link 69 Zafirovska P, Georgievska-Ismail L, Ferati F, Kitanoski D, Kolari A, Nijveldt R. Double Jeopardy - A Case of Overlapping Takotsubo Syndrome and Spontaneous Coronary Dissection. Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2026. link 70 Bai L, Lin S, Liu D, Zhang B, Liu L, Zhao G. Direct oral anticoagulants combined with antiplatelet in the treatment of acute coronary syndrome and atrial fibrillation patients undergoing percutaneous coronary intervention or complicating acute coronary syndrome: a systematic review and meta-analysis. Expert opinion on drug safety 2026. link 71 Chen D, Zhang X, Yang D. Dysregulation of serum hsa_circ_0005870 serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients. Acta cardiologica 2026. link 72 Yamamoto MH, Mizukami T, Mori H, Kobayashi N, Takano M, Kondo S et al.. Impact of absolute stent expansion on two-year clinical outcomes after PCI in patients with acute coronary syndrome: Results from the OCT-guided PCI registry (TACTICS registry). International journal of cardiology 2026. link 73 Meteva D, Pedicino D, Abdelwahed YS, Kränkel N, Anwari E, Leistner DM et al.. Acute coronary syndrome with plaque erosion: clinical characteristics, mechanisms, and unmet needs. European heart journal 2026. link 74 Şahin YB, Kızıltunç E, Candemir M. R2CHADS2 Score: An Effective Risk Stratification Tool for Contrast-Induced Nephropathy and Cardiovascular Outcomes in STEMI Patients Undergoing PCI. Angiology 2026. link 75 Xia Q, Yang S, Pan L, Wang X, Deng C, Gu N et al.. OCT-Derived Virtual Fractional Flow Reserve Associated With 1-Year Outcomes After PCI in ACS Patients. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 76 Li GB, Zhu DQ, He WP, Ouyang SM. A nomogram for predicting in-stent restenosis risk after initial drug-eluting stent implantation in patients with acute coronary syndrome. Heart & lung : the journal of critical care 2026. link 77 Piras L, Tartaglia N, Tocci G, Barbato E, Battistoni A. Bridging the Gap: Exploring Right Ventricular-Pulmonary Artery Coupling in Acute Coronary syndrome-A Pilot Study. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2026. link 78 Lee JH, Lee J, Kim SY, Jeon HS, Lee JW, Ahn SG et al.. Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2026. link 79 Sanz-Sánchez J, Santos Martínez S, Rumiz González E, Oteo Domínguez JF, Tejada Ponce D, Gómez Menchero A et al.. Reduced stent strategy versus conventional percutaneous coronary revascularization in patients presenting with STEMI: design of the COPERNICAN trial. Revista espanola de cardiologia (English ed.) 2026. link 80 Harada K, Kato M, Terashima S, Takeda S, Matsunaga S, Kataoka T et al.. Association between Epicardial Adipose Tissue Volume and Changes in Left Ventricular Ejection Fraction in Patients with Acute Coronary Syndrome. Journal of atherosclerosis and thrombosis 2026. link 81 Tydén M, Batra G, Fellström B, Held C, Lindbäck J, Soveri I et al.. Different eGFR markers and prediction of cardiovascular risk. Journal of internal medicine 2026. link 82 Tsiafoutis I, Zografos T, Karelas D, Varelas P, Manousopoulos K, Nenekidis I et al.. Ticagrelor potentiates cardioprotection by remote ischemic preconditioning: the ticagrelor in remote ischemic preconditioning (TRIP) randomized clinical trial. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2026. link 83 Kerkhof PLM, Heyndrickx GR. Myocardial Layer-Specific Longitudinal Strain for Identification of the Culprit Vessel in Elderly Patients With NSTE-ACS. Echocardiography (Mount Kisco, N.Y.) 2026. link 84 Granata LG, Busà A, Marchetta M, Alagna G, Amico F. Beyond STEMI criteria: The electrocardiographic "South African Flag Sign" revealing an isolated proximal ramus intermedius occlusion. Journal of electrocardiology 2026. link 85 Herrmann A, Mai B, Bai Y, Castillo B, Kar B, Klein K et al.. Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 Cases. The American journal of case reports 2026. link 86 Fatai A, Sattayarom C. Artificial intelligence applications in emergency triage for suspected acute coronary syndrome: a systematic review. International journal of medical informatics 2026. link 87 Alhawamdeh N, Bani Hani DA, Alshraideh JA, Yousef AS, Saleh A. Novel inflammatory markers predict cardiovascular events after percutaneous coronary intervention in patients with acute coronary syndrome. Heart & lung : the journal of critical care 2026. link 88 Mathat B, Compaore Y, David CH, Riche VP, Ryan M, Vourc'h M et al.. Cost-revenue analysis of using a haemoadsorbent membrane in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass and ticagrelor. Archives of cardiovascular diseases 2026. link 89 D'Agostino A, Rosalinda M, Salvatore M, Monica F. Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome. Heart failure clinics 2026. link 90 Yakovlev S, Gvozdeva A. Left Ventricular Pericardial Strangulation: A Diagnostic Challenge in Acute Coronary Syndrome. Methodist DeBakey cardiovascular journal 2026. link 91 Ha C, Lee YJ, Seo JD, Kim H, Moon HW, Hur M et al.. Performance Evaluation of the 2020 European Society of Cardiology 0-hour/1-hour Algorithm Using High-sensitivity Cardiac Troponin I for Non-ST-segment Elevation Acute Coronary Syndrome and Mortality Assessment Based on 1-year Real-world Data. Annals of laboratory medicine 2026. link 92 Liu J, Wei X, Chen D, Lv Z. miR-3613-3p Is a New Diagnostic Indicator of Acute Coronary Syndrome (ACS) That Reduces Endothelial Damage by Targeting Ring Finger and CCCH-Type Domains 1 (RC3H1). Journal of biochemical and molecular toxicology 2026. link 93 Rachwan RJ, Chehab O, Bou Chaaya RG, Daher G, Upadhyay S, Rajput F et al.. A simple clinical scoring model to predict significant left main/three-vessel disease in non-ST elevation acute coronary syndrome: The MADISON score. International journal of cardiology 2026. link 94 Strepkos D, Alexandrou M, Mutlu D, Carvalho PEP, Ser OS, Azzalini L et al.. Death Following Percutaneous Coronary Intervention: Data From the PROGRESS-COMPLICATIONS Registry. The American journal of cardiology 2026. link 95 Mahmoud YA, Al-Khatib A, AlMahmoud Y, Darwish M, Ranjous Y, Etma L et al.. Suicide and suicidal ideation among survivors of acute coronary syndrome: A systematic review and meta-analysis of prevalence and risk factors. Journal of affective disorders 2026. link 96 Gupta A, Tejpal T, Seo C, Fabiano N, Zhao S, Wong S et al.. Mental Disorders as a Risk Factor of Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. JAMA psychiatry 2026. link 97 Zhang X, Han L, Hassan S, Kalra PA, Ritchie J, Diver C et al.. TabulaTime: Novel multimodal deep learning for Acute Coronary Syndrome prediction through environmental and clinical data integration. Artificial intelligence in medicine 2026. link 98 Mishra SR, Marschner S, Min H, Mahendran S, Thiagalingam A, Poulter R et al.. Sex differences in risk factor control and medication adherence post-ACS: insights from the TEXTMEDS randomised clinical trial. Open heart 2026. link 99 Intravaia RCM, Tognola C, Maloberti A, Brucato F, Campione E, Giannattasio C et al.. The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies. Nutrition, metabolism, and cardiovascular diseases : NMCD 2026. link 100 Hatherley J, Davies S, Phillips S, Dakshi A, Miller G, Bailey L et al.. Defining the analytical characteristics of a novel high-sensitivity point-of-care troponin I assay in its intended clinical environment. Clinical chemistry and laboratory medicine 2026. link

    Original source

    1. [1]
    2. [2]
      Intermediate cardiac care units: rationale, resources, and admission criteria. Position statement of the SEC-ACICAC.Viana-Tejedor A, Martínez Losas P, Andrea-Riba R, Corbí-Pascual M, Rosillo S, Alonso JJ et al. Revista espanola de cardiologia (English ed.) (2026)
    3. [3]
      Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey.Angiolillo DJ, Erlinge D, Gale CP, Gorog DA, Ibañez B, Musumeci G et al. International journal of cardiology (2026)
    4. [4]
      Women and men profit equally from cardiac rehabilitation: a secondary analysis of the OPTICARE RCT.Ter Hoeve N, De Bakker M, Sunamura M, Roeters van Lennep JE, Boersma E, Van den Berg-Emons RJG Journal of rehabilitation medicine (2026)
    5. [5]
      Socioeconomic Variation in the Association Between Participation in Cardiac Rehabilitation and Clinical Outcomes in Patients With Acute Coronary Syndrome.Manandi D, Brieger D, Redfern J, Tu Q, Briffa T, Hafiz N et al. Journal of cardiopulmonary rehabilitation and prevention (2026)
    6. [6]
      Respiratory, thoracic, and mediastinal adverse events associated with ticagrelor: A pharmacovigilance study based on FDA adverse event reporting system.Zeng Y, Lu L, Jiang T, Wei G, Zheng W, Chen G Naunyn-Schmiedeberg's archives of pharmacology (2026)
    7. [7]
      CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026.Ozaki Y, Tobe A, Onuma Y, Miyashita K, Kobayashi Y, Amano T et al. Cardiovascular intervention and therapeutics (2026)
    8. [8]
    9. [9]
    10. [10]
    11. [11]
    12. [12]
      Performance of the ESC 0/1 h hs-cTnI algorithm in suspected NSTEMI patients with normal versus abnormal electrocardiograms.Feng ZQ, Xu F, Fu YN, Yang FF, Li Y, Yang BH et al. The American journal of emergency medicine (2026)
    13. [13]
      Comparing physician and advanced care provider use of opioids for treatment of acute chest pain in the emergency department.Laughter C, Alsayyed A, Shubair M, Johnson A, Awad E The American journal of emergency medicine (2026)
    14. [14]
      Extended Pharmacoinvasive PCI Compared to Primary PCI: Insights From Madras Medical College STEMI Registry.Gnanaraj JP, Saaminathan K, Steaphen AP, Sethupathy S, Mohammed I, Kurien S et al. The American journal of cardiology (2026)
    15. [15]
    16. [16]
      Joint effects of pulse pressure and LVEF on 12-month mortality in acute coronary syndrome patients undergoing PCI.De Y, Han Y, Song Y, Zhang X, Wu S, Wang B et al. International journal of cardiology (2026)
    17. [17]
      A Remote Nursing-Guided Secondary Prevention Programme in Acute Coronary Syndrome. The SPRING Randomised Controlled Trial.Fernández-Pombo CN, Aldama-López G, Lorenzo-Carpente M, López-Perez M, Marzoa-Rivas R, Rodríguez-Fernández JÁ et al. Journal of advanced nursing (2026)
    18. [18]
    19. [19]
      Short-Course Potent P2YKulsumritpon N Cardiovascular drugs and therapy (2026)
    20. [20]
      Coronary microvascular dysfunction in patients with acute coronary syndrome and non-obstructive coronary artery disease: a 10-year clinical follow-up study.De Vita A, Marino AG, Cambise N, Lamendola P, Tremamunno S, Mollo F et al. International journal of cardiology (2026)
    21. [21]
    22. [22]
    23. [23]
      The Mental Health-Acute Coronary Syndrome Continuum: Bidirectional Pathophysiological Links and Clinical Implications.Herlaș-Pop A, Radu AF, Radu A, Bungau GS, Tit DM, Babes EE et al. Medical sciences (Basel, Switzerland) (2026)
    24. [24]
      Effect of overweight and obesity on clinical course and prognosis in patients with acute coronary syndromes.Dudzikowska M, Rębak D, Gotlib-Małkowska J, Chmielewski J, Sierpiński R, Goździewska M et al. Annals of agricultural and environmental medicine : AAEM (2026)
    25. [25]
    26. [26]
    27. [27]
      Win statistics applied to registry-based randomized clinical trials.Rylance R, Wagner P, Götberg M, Mohammad MA, Hofmann R, Fröbert O et al. Trials (2026)
    28. [28]
      The Importance of Arterial Stiffness Parameters for Predicting Syntax Score in Acute Coronary Syndrome.Gülle S, Ekmekci C, Akar H, Özdoğan Ö Romanian journal of internal medicine = Revue roumaine de medecine interne (2026)
    29. [29]
      Impact of Comprehensive STEMI Protocol on Process Metrics and Clinical Outcomes in STEMI Patients With Nonsystem Delays.Kumar S, Giri AR, Nair RM, Kassis N, Kumar A, Huded CP et al. The American journal of cardiology (2026)
    30. [30]
      Outcomes and Risk Profiles of Acute Coronary Syndrome Patients Treated With Percutaneous Coronary Intervention: Insights From a Brazilian Tertiary Care Center.Pereira AMB, Rosa AA, Flávio-Reis VHP, Pessoa-Gonçalves YM, Desidério CS, Coelho MFG et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
    31. [31]
    32. [32]
      Unlocking interstitial fluid for acute coronary syndrome diagnosis: ultrasensitive troponin I detection using imprinted polymer nanoparticles.Saczek J, Dann A, Crapnell RD, Banks CE, Johnson RE, Canfarotta F et al. Nanoscale horizons (2026)
    33. [33]
    34. [34]
      Homocysteine activates endothelial TP receptor to promote von Willebrand factor secretion and thrombosis.Zhang J, Jia X, Zhu P, Zhao M, Du H, Yu X et al. Journal of molecular and cellular cardiology (2026)
    35. [35]
      Adversarial Debiasing for Equitable and Fair Detection of Acute Coronary Syndrome Using 12-Lead ECG.Ji RQ, Riek NT, Bouzid Z, Kraevsky-Phillips K, Gokhale T, Zegre-Hemsey JK et al. IEEE transactions on bio-medical engineering (2026)
    36. [36]
      Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.Kovacic JC, Reynolds HR, Alasnag M, Blakeman JR, Ijioma NN, Kim ESH et al. Circulation (2026)
    37. [37]
      ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET Registry.Cirillo P, Di Serafino L, Scalamogna M, De Rosa G, Calabrò P, Antonucci E et al. Angiology (2026)
    38. [38]
      The impact of post discharge virtual cardiac remote monitoring for patients with acute coronary syndrome during HAJJ season 1445H- KAMC experience.Khaled S, Tantawi W, Ahmed WE, Shaikh M, Alkhatib A, Bahattab A et al. International journal of cardiology (2026)
    39. [39]
      Diagnostic accuracy of 18-lead versus 12-lead electrocardiography in acute coronary syndrome: A systematic review and meta-analysis.Koolikad AR, Khan SA, Shahzaib M, Arif B, Singla S, Singla B et al. Journal of electrocardiology (2026)
    40. [40]
      The Role of VEGF-A in Young Patients with Acute Coronary Syndrome.Ocak M, Çömez VV, Yadigaroğlu M, Görgün S, Köprülü D, Güzel M et al. Clinical laboratory (2026)
    41. [41]
      Long-term safety, effectiveness, and cost of rapamycin- vs. everolimus-eluting stents in acute coronary syndrome: a real-world cohort study.Lin X, Wang Y, Tan S, Kuang C, Huang Y, Zhao J et al. International journal of clinical pharmacy (2026)
    42. [42]
      Potent P2YTavares CAM, Guimarães PO, Franken M, Junior JM, Lemos S, Almeida BO et al. Journal of the American College of Cardiology (2026)
    43. [43]
      Acute coronary-occlusion myocardial infarctions: performance of the STEMI criteria and evolving alternative approaches.Tudino R, Richardson E, Gonzalez JM, Barghout M, Ho T, Abbott JD et al. Trends in cardiovascular medicine (2026)
    44. [44]
      Immediate versus delayed coronary angiography in patients with non-ST segment elevation acute coronary syndrome complicated with acute decompensated heart failure: The EARLY-HF randomized clinical trial.Lim Y, Park S, Joo D, Lee YK, Oh S, Lee SH et al. Cardiovascular revascularization medicine : including molecular interventions (2026)
    45. [45]
      Sex Disparities in Acute Myocardial Infarction Diagnosis and Treatment.Imboden MT, Koltner E, Bryant JH, Jones A, Swanson RC, Tam LM et al. The American journal of cardiology (2026)
    46. [46]
    47. [47]
    48. [48]
      Efficacy and Safety of Aspirin-free versus Aspirin-based Strategies in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.Khan M, Janjua MAH, Akhtar SMM, Al-Qaraghuli A, Al-Shammari AS, Al Sakini AS et al. Journal of cardiovascular pharmacology (2026)
    49. [49]
      In-hospital outcomes of percutaneous coronary intervention (PCI) patients with different medical funds: an analysis from Thai PCI registry.Hongsakul T, Chumsantivut S, Siriyotha S, Athisakul S, Sansanayudh N, Thakkinstian A et al. Open heart (2026)
    50. [50]
      Temporal Trends in Acute Coronary Syndrome Incidence in Aboriginal and Non-Aboriginal People in Western Australia.Ahmed M, Wade V, Stacey I, Sodhi-Berry N, Youens D, Haynes E et al. Circulation. Population health and outcomes (2026)
    51. [51]
      Challenges of Coronary Access in Acute Coronary Syndrome With Severe Peripheral Arterial Disease: A Fatal Case.Sahoo SK, Barik R, Sathia S, Mohanty CR Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
    52. [52]
      Dealing With Calcium in STEMI: A Unique Case of Intracoronary Fracture and Rescue of a Guide Catheter Extension.Verdoia M, Viola O, Rognoni A Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
    53. [53]
      Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.Raposeiras-Roubín S, Abu Assi E, Jiménez Méndez C, Mínguez de la Guía E, Pérez Rivera JÁ, Marcos Mangas M et al. Circulation (2026)
    54. [54]
      Right bundle-branch block (RBBB) and acute coronary syndrome (ACS) a narrative review.Roshan PK The American journal of emergency medicine (2026)
    55. [55]
      AI-Driven multi-view learning from CCTA for myocardial infarction diagnosis.Gwizdala J, Salihu A, Senouf O, Meier D, Rotzinger D, Qanadli S et al. The international journal of cardiovascular imaging (2026)
    56. [56]
    57. [57]
      Associations Between Sex, Race/Ethnicity, and HEART Score Guideline Implementation for Cardiac Testing in the Emergency Department.Murray E, Munoz K, Hopkins E, Gravitz S, Haukoos J, Trent S The Journal of emergency medicine (2026)
    58. [58]
      Circulating Markers of Neutrophil Extracellular Traps for Long-Term Prognosis in Patients With Acute Chest Pain.Myrmel GMS, Helseth R, Steiro OT, Tjora HL, Langørgen J, Bjørneklett RO et al. Journal of the American Heart Association (2026)
    59. [59]
      Frailty Modifies the Prognostic Effect of Age Among Older Adults With Acute Coronary Syndrome.Fishman B, Segev A, Ashri S, Lerman TT, Sultani S, Beigel R et al. Journal of the American Heart Association (2026)
    60. [60]
      Diagnostic and prognostic value of the risk factor-weighted clinical likelihood model in acute chest pain and negative troponin.Barbeito-Caamaño C, Bouzas-Mosquera A, Peteiro-Vázquez J, Fuentes-Vivero A, Vilasanchez-Vilar J, López-Vázquez D et al. The American journal of emergency medicine (2026)
    61. [61]
      Safety of Early Coronary Surgery in Antiplatelet Non-Responders: A Retrospective Cohort Study.Brookes JDL, Sadiqi S, Chengalath M, Ring H, Morley C, Hogan K et al. Heart, lung & circulation (2026)
    62. [62]
      Nitroglycerin use in STEMI locations.Heaney B, Zalar K, Flores M, Jessee S, Watkins E JAAPA : official journal of the American Academy of Physician Assistants (2026)
    63. [63]
      Methylergometrine-induced acute coronary vasospasm in a postpartum patient following caesarean delivery of DCDA twins.Nair S, Bhat D, Hebbar S, Upadhyaya R, Bhat K, Bhat M A BMJ case reports (2026)
    64. [64]
      Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCI.Oliva A, Cao D, Shneyderman M, Serrao G, Gitto M, Di Muro FM et al. Journal of thrombosis and thrombolysis (2026)
    65. [65]
      Evaluating the Efficacy of CPS, HEART and TIMI Score in Emergency Department Patients with Non-Traumatic Chest Pain: A Pilot Study.Pozzessere P, Di Lauro M, Incantalupo F, Cinquantasei A, Palazzo S, Lepera ME et al. Medical sciences (Basel, Switzerland) (2026)
    66. [66]
      Endothelial dysfunction in plaque rupture and plaque erosion.Ishii Y, Kure M, Kawasumi H, Numaziri Y, Tanizaki Y, Takei Y et al. Heart and vessels (2026)
    67. [67]
    68. [68]
      Predictors and prognostic value of coronary computed tomography angiography for unrecognized myocardial infarction in patients with chronic coronary syndrome.Teng Y, Hoshino M, Kanaji Y, Sugiyama T, Misawa T, Hada M et al. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese (2026)
    69. [69]
      Double Jeopardy - A Case of Overlapping Takotsubo Syndrome and Spontaneous Coronary Dissection.Zafirovska P, Georgievska-Ismail L, Ferati F, Kitanoski D, Kolari A, Nijveldt R Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) (2026)
    70. [70]
    71. [71]
    72. [72]
      Impact of absolute stent expansion on two-year clinical outcomes after PCI in patients with acute coronary syndrome: Results from the OCT-guided PCI registry (TACTICS registry).Yamamoto MH, Mizukami T, Mori H, Kobayashi N, Takano M, Kondo S et al. International journal of cardiology (2026)
    73. [73]
      Acute coronary syndrome with plaque erosion: clinical characteristics, mechanisms, and unmet needs.Meteva D, Pedicino D, Abdelwahed YS, Kränkel N, Anwari E, Leistner DM et al. European heart journal (2026)
    74. [74]
    75. [75]
      OCT-Derived Virtual Fractional Flow Reserve Associated With 1-Year Outcomes After PCI in ACS Patients.Xia Q, Yang S, Pan L, Wang X, Deng C, Gu N et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
    76. [76]
    77. [77]
      Bridging the Gap: Exploring Right Ventricular-Pulmonary Artery Coupling in Acute Coronary syndrome-A Pilot Study.Piras L, Tartaglia N, Tocci G, Barbato E, Battistoni A High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2026)
    78. [78]
      Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials.Lee JH, Lee J, Kim SY, Jeon HS, Lee JW, Ahn SG et al. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (2026)
    79. [79]
      Reduced stent strategy versus conventional percutaneous coronary revascularization in patients presenting with STEMI: design of the COPERNICAN trial.Sanz-Sánchez J, Santos Martínez S, Rumiz González E, Oteo Domínguez JF, Tejada Ponce D, Gómez Menchero A et al. Revista espanola de cardiologia (English ed.) (2026)
    80. [80]
      Association between Epicardial Adipose Tissue Volume and Changes in Left Ventricular Ejection Fraction in Patients with Acute Coronary Syndrome.Harada K, Kato M, Terashima S, Takeda S, Matsunaga S, Kataoka T et al. Journal of atherosclerosis and thrombosis (2026)
    81. [81]
      Different eGFR markers and prediction of cardiovascular risk.Tydén M, Batra G, Fellström B, Held C, Lindbäck J, Soveri I et al. Journal of internal medicine (2026)
    82. [82]
      Ticagrelor potentiates cardioprotection by remote ischemic preconditioning: the ticagrelor in remote ischemic preconditioning (TRIP) randomized clinical trial.Tsiafoutis I, Zografos T, Karelas D, Varelas P, Manousopoulos K, Nenekidis I et al. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese (2026)
    83. [83]
    84. [84]
      Beyond STEMI criteria: The electrocardiographic "South African Flag Sign" revealing an isolated proximal ramus intermedius occlusion.Granata LG, Busà A, Marchetta M, Alagna G, Amico F Journal of electrocardiology (2026)
    85. [85]
      Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 Cases.Herrmann A, Mai B, Bai Y, Castillo B, Kar B, Klein K et al. The American journal of case reports (2026)
    86. [86]
      Artificial intelligence applications in emergency triage for suspected acute coronary syndrome: a systematic review.Fatai A, Sattayarom C International journal of medical informatics (2026)
    87. [87]
      Novel inflammatory markers predict cardiovascular events after percutaneous coronary intervention in patients with acute coronary syndrome.Alhawamdeh N, Bani Hani DA, Alshraideh JA, Yousef AS, Saleh A Heart & lung : the journal of critical care (2026)
    88. [88]
      Cost-revenue analysis of using a haemoadsorbent membrane in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass and ticagrelor.Mathat B, Compaore Y, David CH, Riche VP, Ryan M, Vourc'h M et al. Archives of cardiovascular diseases (2026)
    89. [89]
      Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome.D'Agostino A, Rosalinda M, Salvatore M, Monica F Heart failure clinics (2026)
    90. [90]
      Left Ventricular Pericardial Strangulation: A Diagnostic Challenge in Acute Coronary Syndrome.Yakovlev S, Gvozdeva A Methodist DeBakey cardiovascular journal (2026)
    91. [91]
    92. [92]
    93. [93]
      A simple clinical scoring model to predict significant left main/three-vessel disease in non-ST elevation acute coronary syndrome: The MADISON score.Rachwan RJ, Chehab O, Bou Chaaya RG, Daher G, Upadhyay S, Rajput F et al. International journal of cardiology (2026)
    94. [94]
      Death Following Percutaneous Coronary Intervention: Data From the PROGRESS-COMPLICATIONS Registry.Strepkos D, Alexandrou M, Mutlu D, Carvalho PEP, Ser OS, Azzalini L et al. The American journal of cardiology (2026)
    95. [95]
      Suicide and suicidal ideation among survivors of acute coronary syndrome: A systematic review and meta-analysis of prevalence and risk factors.Mahmoud YA, Al-Khatib A, AlMahmoud Y, Darwish M, Ranjous Y, Etma L et al. Journal of affective disorders (2026)
    96. [96]
      Mental Disorders as a Risk Factor of Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.Gupta A, Tejpal T, Seo C, Fabiano N, Zhao S, Wong S et al. JAMA psychiatry (2026)
    97. [97]
      TabulaTime: Novel multimodal deep learning for Acute Coronary Syndrome prediction through environmental and clinical data integration.Zhang X, Han L, Hassan S, Kalra PA, Ritchie J, Diver C et al. Artificial intelligence in medicine (2026)
    98. [98]
      Sex differences in risk factor control and medication adherence post-ACS: insights from the TEXTMEDS randomised clinical trial.Mishra SR, Marschner S, Min H, Mahendran S, Thiagalingam A, Poulter R et al. Open heart (2026)
    99. [99]
      The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies.Intravaia RCM, Tognola C, Maloberti A, Brucato F, Campione E, Giannattasio C et al. Nutrition, metabolism, and cardiovascular diseases : NMCD (2026)
    100. [100]
      Defining the analytical characteristics of a novel high-sensitivity point-of-care troponin I assay in its intended clinical environment.Hatherley J, Davies S, Phillips S, Dakshi A, Miller G, Bailey L et al. Clinical chemistry and laboratory medicine (2026)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG